Brief: Todos Medical Releases Preliminary Data From Market Research Study Of Acute And Long COVID Treatment
23/06/2022 12:04
June 23 (Reuters) - Todos Medical Ltd TOMDF.PK :
* TODOS MEDICAL RELEASES PRELIMINARY DATA FROM IRB-WAIVED
TOLLOVID® MARKET RESEARCH STUDY IN ACUTE AND LONG COVID
* TODOS MEDICAL LTD- 83% OF RESPONDENTS WITH ACUTE COVID
WERE
SATISFIED IN STUDY
* TODOS MEDICAL LTD- 68% OF RESPONDENTS WITH LONG COVID WERE
SATISFIED IN STUDY
Source text for Eikon: ID:nGNXbZK7rS
Further company coverage: TOMDF.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Todos Medical
See all newsBrief: Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
Brief: Todos Medical Clia/Cap Lab Provista Submits Emergency Use Authorization Application For Monkeypox Pcr Test To Us FDA
Brief: Todos Medical Provides Corporate Update
Brief: Todos Medical Enters Into $50 Mln Contract To Supply Tollovid, CBD Products To Retail Distributor Company Nerd Hemp
Brief: Todos Medical Establishes Botanical Supplement Manufacturing Capabilities